Item 7.01. Regulation FD Disclosure. On October 8, 2026, Shoulder Innovations, Inc. (the “Company”) issued a press release announcing the limited user release of InSet® Go, the Company's next-generation glenoid implant, for use in anatomic shoulder arthroplasty procedures following the successful completion of the first surgical case.…
Filed Oct 8, 2026Accepted Oct 8, 2026, 7:05 AM EDTCIK 1699350Accession 0001699350-26-000058
Select an item to read the extracted section. The as-filed document remains the primary evidence.
Item 7.01Item 7.01 - Regulation FD Disclosure
Item 7.01. Regulation FD Disclosure.
On October 8, 2026, Shoulder Innovations, Inc. (the “Company”) issued a press release announcing the limited user release of InSet® Go, the Company's next-generation glenoid implant, for use in anatomic shoulder arthroplasty procedures following the successful completion of the first surgical case. A copy of the press release is being furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.
The information contained in this Current Report on Form 8-K (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.